Senda Biosciences is based in Cambridge. It has raised $226M in total funding. Latest round: Series C.
Senda Biosciences is based in Cambridge. Senda Biosciences has raised $226M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in August 2022. The round record for Senda Biosciences runs through 2022; nothing later has been disclosed. Investors on record include Flagship Pioneering, Qatar Investment Authority, Samsung Life Science Fund, Stage 1 Ventures, Bluwave Capital, Longevity Vision Fund and 4 others. 10 distinct backers are named across the disclosed rounds.
Totals shown for Senda Biosciences aggregate every disclosed round on file. To see how that compares, browse the companies in Cambridge and the investors behind them below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026